HK2 and glioblastoma: Although Hexokinase 1 can contribute to cancer, Hexokinase 2 is more frequently overexpressed in various cancers including colorectal, liver, cervical, and metastatic breast cancer and glioblastoma, and its overexpression is associated with a worse survival38–42.